Holista Colltech Limited

Equities

HCT

AU000000HCT4

Biotechnology & Medical Research

Delayed Australian S.E. Other stock markets 01:10:13 2024-03-14 am EDT			5-day change	1st Jan Change
0.01 ^AUD	+11.11%		-.--%	-.--%

Apr. 17	Holista Colltech Requests for Extension of Voluntary Suspension	MT
Mar. 21	Holista Colltech Suspended from Australian Bourse Pending Announcement	MT

Holista Colltech Limited Auditor Raises 'Going Concern' Doubt

March 29, 2022

Holista Colltech Limited filed its Annual on Mar 30, 2022 for the period ending Dec 31, 2021. In this report its auditor, Stantons International, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Latest news about Holista Colltech Limited

Holista Colltech Requests for Extension of Voluntary Suspension	Apr. 16	MT
Holista Colltech Suspended from Australian Bourse Pending Announcement	Mar. 20	MT
Holista Colltech Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Holista Colltech's Customer Receipts Hit AU$1.8 Million in Q4	Jan. 31	MT
Holista Colltech Says Civil Penalty Federal Court Hearings Completed; Shares Climb 17%	Dec. 07	MT
Holista Colltech Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Olista Colltech Limited Announces Board Changes	23-04-05	CI
Holista Colltech Limited Auditor Raises 'Going Concern' Doubt	23-03-30	CI
Holista Colltech Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Holista Colltech Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Holista Colltech's Sales Receipts Jump 55% in Q2	22-07-28	MT
Holista Colltech Limited Announces Test Results on All-Natural Nano Silver Disinfectant	22-04-29	CI
Holista Colltech Receives First Commercial Order from Country Farms	22-04-21	MT
Holista Colltech Limited Auditor Raises 'Going Concern' Doubt	22-03-29	CI
Holista CollTech Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-27	CI
Holista Colltech's Sanitizer Product Demonstrates 12-Hour Effectivity	21-10-29	MT
Holista Colltech's Cash Receipts Rise in Q3	21-10-28	MT
Holista Colltech Limited Announces Natshield Test Results	21-10-28	CI
Holista Colltech : Secures Trademark Nod From Chinese Regulator	21-09-16	MT
Holista CollTech Limited Announces Change of Company Secretary	21-09-01	CI
Holista Colltech Limited Announces Change of Registered Office	21-09-01	CI
Holista Colltech Limited Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-26	CI
Holista CollTech : Corporate Regulator Sues Holista Colltech over Misleading Statements	21-08-05	MT
Holista Colltech Limited Announces Management Changes	21-07-29	CI
Holista Colltech : Sales Revenue Grows 33% in Q2	21-07-28	MT

Chart Holista Colltech Limited

Duration

Period

More charts

Company Profile

Holista CollTech Ltd is a research-driven biotech company. The Company is focused on researching, developing, manufacturing, and marketing health-style products. The Company's segments include Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate. The Supplements segment is involved in the manufacture and wholesale distribution of dietary supplements. The Ovine collagen segment is involved in the manufacture and distribution of cosmetic-grade collagen. The Food ingredients segment is involved in the manufacture and wholesale distribution of healthy food ingredients. The Infection control Solutions segment is involved in the infection control solutions. The Companyâs products include Natshield Spray, Natshield Balm, and Natshield Wipes. Its all-natural products can be used as sanitizers, nasal balms, and as a consumable in the M3 system, which is developed to disinfect quarantine centers, offices, homes, and cars.

Sector

Biotechnology & Medical Research

Calendar

2024-05-16 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
HOLISTA COLLTECH LIMITED	-.--%	1.81M
IQVIA HOLDINGS INC.	+0.67%	42.19B
LONZA GROUP AG	+44.30%	40.15B
CELLTRION, INC.	-6.20%	28.31B
ICON PUBLIC LIMITED COMPANY	+6.55%	24.63B
ALNYLAM PHARMACEUTICALS, INC.	-21.66%	18.2B
MEDPACE HOLDINGS, INC.	+29.96%	12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.57%	11.76B
UNITED THERAPEUTICS CORPORATION	+16.03%	10.4B
BIO-TECHNE CORPORATION	-4.80%	9.94B

Other Biotechnology & Medical Research